Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? (Q45812001)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 October 2012

edit

Language	Label	Description	Also known as
English	Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?	scientific article published on 14 October 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

title

Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

main subject

adalimumab

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

author

Satish Keshav

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

author name string

C Reenaers

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

E Louis

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

J Belaiche

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

L Seidel

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

S Travis

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

language of work or name

English

0 references

publication date

14 October 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

published in

Alimentary Pharmacology & Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

volume

36

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

issue

11-12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

page(s)

1040-1048

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

cites work

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Adalimumab safety in global clinical trials of patients with Crohn's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Analysis of a cluster randomized trial with binary outcome data using a multi-level model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

The natural history of adult Crohn's disease in population-based cohorts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Infliximab, azathioprine, or combination therapy for Crohn's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FAPT.12076

retrieved

21 January 2018

Identifiers

DOI

10.1111/APT.12076

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

PubMed publication ID

23061650

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23061650

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23061650

ResearchGate publication ID

232248696

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45812001&oldid=1402229185"